- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Trastuzumab (Herceptin®)
Total 14979 results
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Dana-Farber Cancer InstituteNovartisCompleted
-
Hoffmann-La RocheCompletedGastric CancerAustria, Belgium, Brazil, Canada, China, Croatia, Finland, Hungary, Italy, Korea, Republic of, Mexico, Poland, Spain, Turkey, United States, Kazakhstan, Peru, Russian Federation, Switzerland, Taiwan, Thailand, Germany, Japan, Malaysia, ... and more
-
Hoffmann-La RocheCompletedBreast CancerFrance, Spain, Canada, Australia, Russian Federation, Austria, United Kingdom, Italy, Turkey, Bosnia and Herzegovina, Argentina, Romania, Brazil, Mexico, Uruguay, Czech Republic
-
Memorial Sloan Kettering Cancer CenterNovartisCompleted
-
The University of Texas Health Science Center at...National Cancer Institute (NCI)Withdrawn
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Anglo Celtic Cooperative Oncology GroupCompleted
-
Warwick Medical SchoolUnknown
-
Genentech, Inc.Completed
-
Hoffmann-La RocheActive, not recruiting
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu PositiveUnited States
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompleted
-
Amsterdam UMC, location VUmcAstraZenecaRecruitingBreast Cancer | Gastric Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric CancerNetherlands
-
Memorial Sloan Kettering Cancer CenterCompletedEsophagogastric CancerUnited States
-
Shanghai Zhongshan HospitalCompleted
-
National Cancer Institute, FranceCompleted
-
National Cancer Institute (NCI)TerminatedColorectal CancerUnited States
-
Spanish Breast Cancer Research GroupSanofi; Hoffmann-La Roche; Amgen; CephalonCompleted
-
Bhuvaneswari RamaswamyUniversity of Pittsburgh; Genentech, Inc.; Case Comprehensive Cancer CenterCompleted
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Severance HospitalUnknownBreast CancerKorea, Republic of
-
Hellenic Oncology Research GroupUniversity Hospital of CreteTerminated
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingSolid Tumor | Haematological MalignancyUnited Kingdom
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerUnited States, Japan
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
Medical University of ViennaDaiichi Sankyo, Inc.CompletedBreast Cancer Stage IVAustria
-
Meiji Seika Pharma Co., Ltd.Dong-A PharmaceuticalCompleted
-
Finnish Breast Cancer GroupCompleted
-
Augusta UniversityUniversity of Iowa; Teikyo UniversityRecruitingFructose IntoleranceUnited States
-
RemeGen Co., Ltd.Recruiting
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Women and Infants Hospital of Rhode...CompletedBreast CancerUnited States
-
Washington University School of MedicineUnited States Department of Defense; Puma Biotechnology, Inc.CompletedBreast NeoplasmsUnited States, Canada
-
NYU Langone HealthTerminatedBreast CancerUnited States
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingHER2 Positive Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7United States
-
Daiichi SankyoAstraZenecaRecruitingGastroesophageal Junction Adenocarcinoma | Gastric Cancer, AdenocarcinomaHong Kong, Korea, Republic of, France, United Kingdom, Spain, China, Ireland, Brazil, Japan, Singapore, Belgium, Israel, Russian Federation, Argentina, Chile, Hungary, Poland, Portugal, Taiwan, Turkey, Ukraine, Germany, Romania, Italy
-
National Cancer Center Hospital EastDaiichi Sankyo Co., Ltd.RecruitingGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
University of Alabama at BirminghamRecruiting
-
Jules Bordet InstituteUnknownBreast Cancer | Metastatic CancerBelgium
-
National Cancer Centre, SingaporeCompletedHER 2 Positive Advanced Gastric CancerSingapore
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
Cancer Trials IrelandRecruitingHER2-positive Breast CancerIreland
-
University of North Carolina, Chapel HillCompleted
-
AstraZenecaDaiichi Sankyo Co., Ltd.CompletedGastric or Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
Byondis B.V.CompletedSolid TumorsNetherlands, Belgium, United Kingdom, Spain
-
Memorial Sloan Kettering Cancer CenterCompletedBreast CancerUnited States
-
Hospital Affiliated to Military Medical Science...Unknown
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting